CN105949173B - A kind of preparation method of aspartic acid laumosaren - Google Patents

A kind of preparation method of aspartic acid laumosaren Download PDF

Info

Publication number
CN105949173B
CN105949173B CN201610354661.3A CN201610354661A CN105949173B CN 105949173 B CN105949173 B CN 105949173B CN 201610354661 A CN201610354661 A CN 201610354661A CN 105949173 B CN105949173 B CN 105949173B
Authority
CN
China
Prior art keywords
aspartic acid
water
lomefloxacin
reaction
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201610354661.3A
Other languages
Chinese (zh)
Other versions
CN105949173A (en
Inventor
李怀生
李东倡
武玄之
伊文峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henan Jingkang Pharmaceutical Co Ltd
Original Assignee
Henan Jingkang Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan Jingkang Pharmaceutical Co Ltd filed Critical Henan Jingkang Pharmaceutical Co Ltd
Priority to CN201610354661.3A priority Critical patent/CN105949173B/en
Publication of CN105949173A publication Critical patent/CN105949173A/en
Application granted granted Critical
Publication of CN105949173B publication Critical patent/CN105949173B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to a kind of preparation methods of anti-infectious agent,More particularly to a kind of preparation method of aspartic acid laumosaren,The preparation process of the preparation method is by lomefloxacin hydrochloride and water,Alkaline aqueous solution proportionally carries out neutralization reaction,Obtain Lomefloxacin base,By the Lomefloxacin base and L L-aminobutanedioic acids of neutralization reaction generation,Water proportionally carries out salt-forming reaction,Obtain aspartic acid laumosaren wet product,By Lomefloxacin base and L L-aminobutanedioic acids,The mother liquor of purified water salt-forming reaction is refined,Obtain aspartic acid laumosaren wet product,Acquisition finished product finally is dried in aspartic acid laumosaren wet product,Generally,The present invention carries out reaction and effectively reduces production cost in water,Improve reaction speed,Improve the security in production process,Improve Business Economic Benefit,There is high practical value.

Description

A kind of preparation method of aspartic acid laumosaren
Technical field
The present invention relates to a kind of preparation methods of anti-infectious agent, and in particular to a kind of preparation side of aspartic acid laumosaren Method.
Background technology
Lomefloxacin (Lomefloxacin) is the 3rd generation carbostyril family antibacterial drugs, to including the gram of Pseudomonas aeruginosa Negative bacterium and positive bacteria have broad-spectrum antibacterial action, at present, respiratory tract caused by being widely used in sensitive bacterial, urogenital tract, The treatments such as biliary tract, enteron aisle, skin soft-tissue infection and tympanitis, nasosinusitis, the common its esters of clinic.L-aminobutanedioic acid Lome is husky Star (LomefloxacinAspartate) is its acylate, right for relatively common inorganic acid salt such as lomefloxacin hydrochloride The irritation smaller of human body, the tolerance of patient are more preferable.But salt-forming reaction of the prior art is anti-in ethanol water Should, and ethyl alcohol cost is higher, therefore it is imperative to improve aspartic acid laumosaren preparation process.
The content of the invention
It is an object of the invention to overcome deficiency of the prior art and low, the production method letter that provides a kind of production cost It is single, a kind of preparation method for aspartic acid laumosaren that finished product is stablized.
The technical proposal of the invention is realized in this way:A, neutralization reaction:Weigh lomefloxacin hydrochloride and alkaline aqueous solution Middle OH-The molar ratio of content is 1:1.0 ~ 1.2 lomefloxacin hydrochloride and alkaline aqueous solution is spare, weighs lomefloxacin hydrochloride The water that 400 ~ 800 times of molal quantity is added in reaction kettle, and addition weighs spare lomefloxacin hydrochloride and is stirred, and heats to 60-90 DEG C makes lomefloxacin hydrochloride be dissolved completely in water, starts that alkaline aqueous solution is slowly added dropwise, adjust the pH value of solution for 6 ~ 8, heat preservation carry out reaction 1 ~ 2 it is small when, reaction solution is carried out after the completion of reaction to be cooled to room temperature;B, centrifugal drying material:By neutralization reaction Liquid carries out centrifugal drying material, and is eluted using water into filtrate without chlorion, obtains Lomefloxacin base wet product;C, it is anti-into salt It should:According to 1:1:50 ~ 70 molar ratio weighs Lomefloxacin base, L-ASPARTIC ACID, water respectively, and the water weighed, Lome is husky Star base, L-ASPARTIC ACID are sequentially added in retort, are stirred, and heating makes retort be warming up to 50 ~ 95 DEG C, and heat preservation carries out When reaction 2 ~ 4 is small, aspartic acid laumosaren crude product solution is obtained;D, decolorization filtering:It is molten to aspartic acid laumosaren crude product Medicinal carbon is added in liquid, is stirred absorption 30 minutes, heat filtering press filtration filtrate enters in crystallizing tank;E, crystallization centrifugation: It is stirred, after being naturally cooling to 40 ~ 60 DEG C, cooling water is led in crystallizing tank makes temperature be reduced to less than 30 DEG C, progress blowing Centrifugation, elutes filter cake using ethanol water, obtains aspartic acid laumosaren wet product and mother liquor;F, mother liquor refines: Mother liquor is added in treatment tank, stirring is opened, after being evacuated to -0.1 ~ -0.07MPa, is heated to 50 ~ 90 DEG C and is depressurized It is concentrated into when mother liquor volume reduces about 2/3 and stops concentration, release vacuum addition medicinal carbon, be warming up to 60 ~ 90 DEG C and protected Temperature stirring 30 minutes, heat filtering press filtration are crystallized, blowing centrifugation, filter cake are eluted with ethanol water into crystallizing tank, Obtain aspartic acid laumosaren wet product;G, dries pulverizing is packed:The aspartic acid laumosaren that step e and step f is obtained Wet product is packed into baking pan, and baking pan is top-down to be encased on drying vehicle, and drying vehicle is pushed into heated-air circulation oven and is dried, 80 ~ 88 DEG C of oven temperature is controlled, is dried to material moisture≤3.5%, carries out cooling discharge, crush, weigh as needed, It dispenses into complex pocket.
The alkaline aqueous solution is ammonium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate, the aqueous solution of sodium acid carbonate.
Alcoholic strength >=50% in the ethanol water.
The water is water of the drinking water through hyoscine made from the way of distillation, ion-exchange, hyperfiltration.
The beneficial effect comprise that:Lomefloxacin base and L-ASPARTIC ACID are dissolved in during salt-forming reaction In water, Lomefloxacin base and L-ASPARTIC ACID is made to be reacted in water, improve reaction speed, effectively reduce and be produced into This, economizes on resources, improves the safety coefficient in production process, avoided endangering direct labor's health, effectively reduce door The production cost of winter propylhomoserin Lomefloxacin, promotes promoting the use of for aspartic acid laumosaren.
Specific embodiment
Below to embodiments of the present invention further instruction.
Embodiment 1
A kind of preparation method of aspartic acid laumosaren, the aspartic acid laumosaren preparation method include following Step:A, neutralization reaction:The molar ratio for weighing lomefloxacin hydrochloride and potassium hydroxide is 1:1 lomefloxacin hydrochloride and hydrogen-oxygen Change aqueous solutions of potassium is spare, and the water for weighing 600 times of lomefloxacin hydrochloride molal quantity is added in reaction kettle, and addition weighs spare hydrochloric acid Lomefloxacin is stirred, and heating to 60 DEG C makes lomefloxacin hydrochloride be dissolved completely in water, starts that hydrogen-oxygen is slowly added dropwise Change aqueous solutions of potassium, adjust the pH value of solution as 7, heat preservation carry out reaction 2 it is small when, reaction solution be cooled to often after the completion of reaction Temperature;B, centrifugal drying material:Neutralization reaction liquid is subjected to centrifugal drying material, and is eluted using water into filtrate without chlorion, is obtained Lomefloxacin base wet product;C, salt-forming reaction:According to 1:1:50 molar ratio weighs Lomefloxacin base, L- winter ammonia respectively Acid, water, the water weighed, Lomefloxacin base, L-ASPARTIC ACID are sequentially added in retort, are stirred, and heating makes reaction Tank is warming up to 95 DEG C, heat preservation carry out reaction 2 it is small when, obtain aspartic acid laumosaren crude product solution;D, decolorization filtering:Xiang Mendong Medicinal carbon is added in propylhomoserin Lomefloxacin crude product solution, is stirred absorption 30 minutes, heat filtering press filtration filtrate enters knot In brilliant tank;E, crystallization centrifugation:It is stirred, after being naturally cooling to 60 DEG C, logical cooling water makes temperature be reduced to 30 in crystallizing tank Below DEG C, blowing centrifugation is carried out, filter cake is eluted using ethanol water, obtains aspartic acid laumosaren wet product and mother Liquid;F, mother liquor refines:By mother liquor add in treatment tank in, open stirring, after being evacuated to -0.09MPa, be heated to 80 DEG C into The mother liquor volume that row is concentrated under reduced pressure into stops concentration when reducing about 2/3, releases vacuum addition medicinal carbon, is warming up to 90 DEG C of progress Insulated and stirred 30 minutes, heat filtering press filtration are crystallized, blowing centrifugation into crystallizing tank, filter cake are drenched with ethanol water It washes, obtains aspartic acid laumosaren wet product;G, dries pulverizing is packed:L-aminobutanedioic acid Lome that step e and step f is obtained is husky Star wet product is packed into baking pan, and baking pan is top-down to be encased on drying vehicle, and drying vehicle, which is pushed into heated-air circulation oven, to be dried It is dry, 80 DEG C of oven temperature is controlled, is dried to material moisture≤3.5%, carries out cooling discharge, crush, weigh as needed, It dispenses into complex pocket.
Alcoholic strength >=50% in the ethanol water.
The water is water of the drinking water through hyoscine made from the way of distillation.
Generally, the present invention carries out reaction and effectively reduces production cost in water, improves reaction speed, and raising produced Security in journey has the advantages that high practical value.
Embodiment 2
A kind of preparation method of aspartic acid laumosaren, the aspartic acid laumosaren preparation method include following Step:A, neutralization reaction:The molar ratio for weighing lomefloxacin hydrochloride and sodium hydroxide is 1:1.1 lomefloxacin hydrochloride and hydrogen Aqueous solution of sodium oxide is spare, and the water for weighing 800 times of lomefloxacin hydrochloride molal quantity is added in reaction kettle, and addition weighs spare salt Lomefloxacin hydrochloride is stirred, and heating to 80 DEG C makes lomefloxacin hydrochloride be dissolved completely in water, starts that hydrogen is slowly added dropwise Aoxidize aqueous solutions of potassium, adjust the pH value of solution as 8, heat preservation carry out reaction 1 it is small when, reaction solution is cooled to after the completion of reaction Room temperature;B, centrifugal drying material:Neutralization reaction liquid is subjected to centrifugal drying material, and is eluted using water into filtrate without chlorion, is obtained Obtain Lomefloxacin base wet product;C, salt-forming reaction:According to 1:1:70 molar ratio weighs Lomefloxacin base, L- winter ammonia respectively Acid, water, the water weighed, Lomefloxacin base, L-ASPARTIC ACID are sequentially added in retort, are stirred, and heating makes reaction Tank is warming up to 60 DEG C, heat preservation carry out reaction 3 it is small when, obtain aspartic acid laumosaren crude product solution;D, decolorization filtering:Xiang Mendong Medicinal carbon is added in propylhomoserin Lomefloxacin crude product solution, is stirred absorption 30 minutes, heat filtering press filtration filtrate enters knot In brilliant tank;E, crystallization centrifugation:It is stirred, after being naturally cooling to 40 DEG C, logical cooling water makes temperature be reduced to 30 in crystallizing tank Below DEG C, blowing centrifugation is carried out, filter cake is eluted using ethanol water, obtains aspartic acid laumosaren wet product and mother Liquid;F, mother liquor refines:By mother liquor add in treatment tank in, open stirring, after being evacuated to -0.07MPa, be heated to 50 DEG C into The mother liquor volume that row is concentrated under reduced pressure into stops concentration when reducing about 2/3, releases vacuum addition medicinal carbon, is warming up to 80 DEG C of progress Insulated and stirred 30 minutes, heat filtering press filtration are crystallized, blowing centrifugation into crystallizing tank, filter cake are drenched with ethanol water It washes, obtains aspartic acid laumosaren wet product;G, dries pulverizing is packed:L-aminobutanedioic acid Lome that step e and step f is obtained is husky Star wet product is packed into baking pan, and baking pan is top-down to be encased on drying vehicle, and drying vehicle, which is pushed into heated-air circulation oven, to be dried It is dry, 88 DEG C of oven temperature is controlled, is dried to material moisture≤3.5%, carries out cooling discharge, crush, weigh as needed, It dispenses into complex pocket.
Alcoholic strength >=50% in the ethanol water.
The water is the water of hyoscine made from hyperfiltration.
Generally, the present invention carries out reaction and effectively reduces production cost in water, improves reaction speed, and raising produced Security in journey improves Business Economic Benefit, has the advantages that high practical value.

Claims (4)

1. a kind of preparation method of aspartic acid laumosaren, it is characterised in that:The aspartic acid laumosaren preparation side Method comprises the following steps:A, neutralization reaction:Weigh lomefloxacin hydrochloride and OH in alkaline aqueous solution-The molar ratio of content is 1: 1.0 ~ 1.2 lomefloxacin hydrochloride and alkaline aqueous solution are spare, the water for weighing 400 ~ 800 times of lomefloxacin hydrochloride molal quantity adds in In reaction kettle, addition weighs spare lomefloxacin hydrochloride and is stirred, and heating to 60-90 DEG C makes lomefloxacin hydrochloride complete Fully dissolved in water starts that alkaline aqueous solution is slowly added dropwise, and adjusts the pH value of solution as 6 ~ 8, heat preservation carry out reaction 1 ~ 2 it is small when, Reaction solution is carried out after the completion of reaction to be cooled to room temperature;B, centrifugal drying material:Neutralization reaction liquid is subjected to centrifugal drying material, and uses water It is eluted into filtrate without chlorion, obtains Lomefloxacin base wet product;C, salt-forming reaction:According to 1:1:50 ~ 70 mole Than weighing Lomefloxacin base, L-ASPARTIC ACID, water respectively, the water weighed, Lomefloxacin base, L-ASPARTIC ACID are added successively Enter in retort, be stirred, heating makes retort be warming up to 50 ~ 95 DEG C, heat preservation carry out reaction 2 ~ 4 it is small when, obtain door winter ammonia Lomefloxacin hydrochloride crude product solution;D, decolorization filtering:Medicinal carbon is added in into aspartic acid laumosaren crude product solution, is carried out Stirring and adsorbing 30 minutes, heat filtering press filtration filtrate enter in crystallizing tank;E, crystallization centrifugation:It is stirred, is naturally cooling to 40 ~ 60 After DEG C, cooling water is led in crystallizing tank makes temperature be reduced to less than 30 DEG C, progress blowing centrifugation, using ethanol water to filter cake It is eluted, obtains aspartic acid laumosaren wet product and mother liquor;F, mother liquor refines:Mother liquor is added in treatment tank, unlatching is stirred It mixes, after being evacuated to -0.1 ~ -0.07MPa, when being heated to 50 ~ 90 DEG C and be concentrated under reduced pressure into mother liquor volume and reduce about 2/3 Stop concentration, release vacuum addition medicinal carbon, be warming up to 60 ~ 90 DEG C and carry out insulated and stirred 30 minutes, heat filtering press filtration into Crystallizing tank is crystallized, blowing centrifugation, filter cake is eluted with ethanol water, obtains aspartic acid laumosaren wet product; G, dries pulverizing is packed:The aspartic acid laumosaren wet product that step e and step f is obtained is packed into baking pan, and baking pan is from top to bottom Be encased on drying vehicle, drying vehicle is pushed into heated-air circulation oven and is dried, control 80 ~ 88 DEG C of oven temperature, drying To material moisture≤3.5%, cooling discharge is carried out, crushes, weigh, dispensed into complex pocket as needed.
2. a kind of preparation method of aspartic acid laumosaren according to claim 1, it is characterised in that:The alkalescence Aqueous solution is ammonium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate, the aqueous solution of sodium acid carbonate.
3. a kind of preparation method of aspartic acid laumosaren according to claim 1, it is characterised in that:The ethyl alcohol Alcoholic strength >=50% in aqueous solution.
4. a kind of preparation method of aspartic acid laumosaren according to claim 1, it is characterised in that:The water is Water of the drinking water through hyoscine made from the way of distillation, ion-exchange, hyperfiltration.
CN201610354661.3A 2016-05-26 2016-05-26 A kind of preparation method of aspartic acid laumosaren Expired - Fee Related CN105949173B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610354661.3A CN105949173B (en) 2016-05-26 2016-05-26 A kind of preparation method of aspartic acid laumosaren

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610354661.3A CN105949173B (en) 2016-05-26 2016-05-26 A kind of preparation method of aspartic acid laumosaren

Publications (2)

Publication Number Publication Date
CN105949173A CN105949173A (en) 2016-09-21
CN105949173B true CN105949173B (en) 2018-05-18

Family

ID=56909742

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610354661.3A Expired - Fee Related CN105949173B (en) 2016-05-26 2016-05-26 A kind of preparation method of aspartic acid laumosaren

Country Status (1)

Country Link
CN (1) CN105949173B (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69106297T2 (en) * 1990-09-28 1995-05-24 Kyowa Hakko Kogyo Kk Process for the preparation of crystals of a salt of acidic amino acid and basic amino acid.
CN101844995A (en) * 2010-05-13 2010-09-29 上海李氏化学科技有限公司 Preparation method of L-ornithine-L-aspartate
CN102276582A (en) * 2011-08-10 2011-12-14 天津市汉康医药生物技术有限公司 Lomefloxacin aspartate compound
CN104058981A (en) * 2013-03-18 2014-09-24 辽宁科泰生物基因制药股份有限公司 Preparation method of ornithine aspartate

Also Published As

Publication number Publication date
CN105949173A (en) 2016-09-21

Similar Documents

Publication Publication Date Title
CN102504942B (en) Process for preparing high quality tea oil
CN101560252B (en) Method for extracting zein by microwave
CN102239959B (en) Preparation method of ion activation liquid
WO2018103118A1 (en) Fermented soybean whey beverage and preparation method thereof
CN103113985A (en) Process for manufacturing high-quality tea oil
CN102605108A (en) Method for producing xylose by using eucalyptus pulp pre-hydrolyzing liquid
CN102775340A (en) Method for synthesizing pyroglutamic calcium glutamate with shells serving as calcium sources
CN104893005A (en) Method for preparing VI-type slowly-digested starch through ultrasonically-assisted acid-base sedimentation
CN106360718A (en) Extraction technology of aloe vera gels
CN108503677B (en) Method for extracting sialic acid from cubilose
CN101829060B (en) Preparation method of clindamycin phosphate powder for injection
CN111087486B (en) Novel continuous preparation method of resistant dextrin dietary fiber
CN105949173B (en) A kind of preparation method of aspartic acid laumosaren
CN104725218A (en) Method for extracting and purifying hydroxycitric acid from garcinia cambogia
CN103467327A (en) Cleaning production method of medicinal glutamic acid
CN102838451A (en) Method of preparing xylitol by utilizing of corncob
CN103044571A (en) Iron dextran bulk drug and preparation method thereof
CN102321701B (en) Biological preparation method of D-mannose
JP2002058446A (en) Rice young leaf powder
CN106478573A (en) A kind of preparation method of pharmaceutical grade dehydroactic acid sodium
CN106306990A (en) Method for reducing content of tannin in chaenomeles speciosa
CN101121672A (en) Betaine phosphate and its producing method and applicaiton
CN1044364C (en) Medicine for curing enteritis and ulcer colitis and prepn. method thereof
CN116162178B (en) Process for improving extraction rate of Phellinus linteus polysaccharide
CN106606580A (en) Drug for treating dental ulcer

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20180518

Termination date: 20210526